Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel telomerase inhibitors covered by Cancer Research Technology patent

Aug. 27, 2003

Approval for pediatric extension of Fludara

Aug. 26, 2003

Approvable letter for Zometa for patients with bone metastases from advanced cancer

Aug. 26, 2003

Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial

Aug. 26, 2003

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Aug. 26, 2003

Good toxicity profile reported for squalamine in patients with solid tumors

Aug. 26, 2003

Local methotrexate reported to inhibit tumor progression in mice

Aug. 26, 2003

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Aug. 25, 2003

Thalidomide recommended for approval in Australia

Aug. 25, 2003

Phase I bridging study of LEP-ETU commences

Aug. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...